<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35383280</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2399-3642</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Communications biology</Title><ISOAbbreviation>Commun Biol</ISOAbbreviation></Journal><ArticleTitle>Cell environment shapes TDP-43 function with implications in neuronal and muscle disease.</ArticleTitle><Pagination><StartPage>314</StartPage><MedlinePgn>314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s42003-022-03253-8</ELocationID><Abstract><AbstractText>TDP-43 (TAR DNA-binding protein 43) aggregation and redistribution are recognised as a hallmark of amyotrophic lateral sclerosis and frontotemporal dementia. As TDP-43 inclusions have recently been described in the muscle of inclusion body myositis patients, this highlights the need to understand the role of TDP-43 beyond the central nervous system. Using RNA-seq, we directly compare TDP-43-mediated RNA processing in muscle (C2C12) and neuronal (NSC34) mouse cells. TDP-43 displays a cell-type-characteristic behaviour targeting unique transcripts in each cell-type, which is due to characteristic expression of RNA-binding proteins, that influence TDP-43's performance and define cell-type specific splicing. Among splicing events commonly dysregulated in both cell lines, we identify some that are TDP-43-dependent also in human cells. Inclusion levels of these alternative exons are altered in tissues of patients suffering from FTLD and IBM. We therefore propose that TDP-43 dysfunction contributes to disease development either in a common or a tissue-specific manner.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#x160;u&#x161;njar</LastName><ForeName>Ur&#x161;a</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x160;krabar</LastName><ForeName>Neva</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Tumour Virology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Generatio GmbH, Center for Animal, Genetics, T&#xfc;bingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Anna-Leigh</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbassi</LastName><ForeName>Yasmine</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phatnani</LastName><ForeName>Hemali</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NYGC ALS Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Cortese</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Behaviour Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cereda</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genomic and post-Genomic Unit, IRCCS Mondino Foundation, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bugiardini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardani</LastName><ForeName>Rosanna</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>BioCor Biobank, UOC SMEL-1 of Clinical Pathology, IRCCS-Policlinico San Donato, San Donato Milanese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meola</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripolone</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moggio</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4820-2897</Identifier><AffiliationInfo><Affiliation>Department of Life Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secrier</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2758-1741</Identifier><AffiliationInfo><Affiliation>UCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fratta</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8762-8188</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buratti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1356-9074</Identifier><AffiliationInfo><Affiliation>Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. buratti@icgeb.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MC_PC_MR/S022708/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S006508/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W005190/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/T001712/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Biol</MedlineTA><NlmUniqueID>101719179</NlmUniqueID><ISSNLinking>2399-3642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012326" MajorTopicYN="N">RNA Splicing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Phatnani</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fratta</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kwan</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sareen</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broach</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simmons</LastName><ForeName>Z</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arcila-Londono</LastName><ForeName>X</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lee</LastName><ForeName>E B</ForeName><Initials>EB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Van Deerlin</LastName><ForeName>V M</ForeName><Initials>VM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shneider</LastName><ForeName>N A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fraenkel</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ostrow</LastName><ForeName>L W</ForeName><Initials>LW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baas</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berry</LastName><ForeName>J D</ForeName><Initials>JD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butovsky</LastName><ForeName>O</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baloh</LastName><ForeName>R H</ForeName><Initials>RH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shalem</LastName><ForeName>Ophir</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heiman-Patterson</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefanis</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chandran</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pal</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malaspina</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hammell</LastName><ForeName>M G</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Patsopoulos</LastName><ForeName>N A</ForeName><Initials>NA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubnau</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poss</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zhang</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zaitlen</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hornstein</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>T M</ForeName><Initials>TM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dardiotis</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bowser</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Menon</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harms</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Atassi</LastName><ForeName>N</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lange</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacGowan</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>McMillan</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aronica</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harris</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravits</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Crary</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thompson</LastName><ForeName>L M</ForeName><Initials>LM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raj</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Paganoni</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Adams</LastName><ForeName>D J</ForeName><Initials>DJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Babu</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drory</LastName><ForeName>V</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gotkine</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Broce</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Phillips-Cremins</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nath</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Finkbeiner</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cox</LastName><ForeName>G A</ForeName><Initials>GA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35383280</ArticleId><ArticleId IdType="pmc">PMC8983780</ArticleId><ArticleId IdType="doi">10.1038/s42003-022-03253-8</ArticleId><ArticleId IdType="pii">10.1038/s42003-022-03253-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Birsa N, Bentham MP, Fratta P. Cytoplasmic functions of TDP-43 and FUS and their role in ALS. Semin. Cell Dev. Biol. 2020;99:193&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">31132467</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Buratti E. TDP-43 autoregulation: implications for disease. J. Mol. Neurosci. 2011;45:473&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">21681666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ederle H, Dormann D. TDP-43 and FUS en route from the nucleus to the cytoplasm. FEBS Lett. 2017;591:1489&#x2013;1507.</Citation><ArticleIdList><ArticleId IdType="pubmed">28380257</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. TDP-43: gumming up neurons through protein&#x2013;protein and protein&#x2013;RNA interactions. Trends Biochem. Sci. 2012;37:237&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">22534659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti, E. Functional significance of TDP-43 mutations in disease. Adv. Genet.91, 1&#x2013;53 (Elsevier, 2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26410029</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Salajegheh M, et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis: redistribution of TDP-43. Muscle Nerve. 2009;40:19&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700211</ArticleId><ArticleId IdType="pubmed">19533646</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol., Neurosurg. Psychiatry. 2008;79:1186&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2586594</ArticleId><ArticleId IdType="pubmed">18796596</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, et al. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis: Optineurin in inclusion body myositis. Neuropathol. Appl. Neurobiol. 2013;39:406&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">22860700</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms MB, et al. Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy. Ann. Neurol. 2012;71:407&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314127</ArticleId><ArticleId IdType="pubmed">22334415</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler TO, et al. TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature. 2018;563:508&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. TDP-43 post-translational modifications in health and disease. Expert Opin. Ther. Targets. 2018;22:279&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">29431050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele M, et al. The human transcriptome across tissues and individuals. Science. 2015;348:660&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547472</ArticleId><ArticleId IdType="pubmed">25954002</ArticleId></ArticleIdList></Reference><Reference><Citation>Appocher C, et al. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 2017;45:8026&#x2013;8045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570092</ArticleId><ArticleId IdType="pubmed">28575377</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappelli S, Romano M, Buratti E. Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human RNA binding proteins implicated in mRNA processing mechanisms. Front. Mol. Biosci. 2018;5:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6125337</ArticleId><ArticleId IdType="pubmed">30214903</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabili MN, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25:1915&#x2013;1927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3185964</ArticleId><ArticleId IdType="pubmed">21890647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, et al. Identifying and functionally characterizing tissue-specific and ubiquitously expressed human lncRNAs. Oncotarget. 2016;7:7120&#x2013;7133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872773</ArticleId><ArticleId IdType="pubmed">26760768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig N, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865&#x2013;3877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856985</ArticleId><ArticleId IdType="pubmed">26921406</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Investig. 2020;130:6080&#x2013;6092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598060</ArticleId><ArticleId IdType="pubmed">32790644</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiesel FC, Weber SS, Supper J, Zell A, Kahle PJ. TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR. Nucleic Acids Res. 2012;40:2668&#x2013;2682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315294</ArticleId><ArticleId IdType="pubmed">22121224</ArticleId></ArticleIdList></Reference><Reference><Citation>De Conti L, et al. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways. Nucleic Acids Res. 2015;43:8990&#x2013;9005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4605304</ArticleId><ArticleId IdType="pubmed">26261209</ArticleId></ArticleIdList></Reference><Reference><Citation>Prpar Mihevc S, Baralle M, Buratti E, Rogelj B. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci. Rep. 2016;6:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, et al. Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Proc. Natl Acad. Sci. USA. 2012;109:21510&#x2013;21515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535614</ArticleId><ArticleId IdType="pubmed">23236149</ArticleId></ArticleIdList></Reference><Reference><Citation>Budini M, Romano V, Quadri Z, Buratti E, Baralle FE. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Hum. Mol. Genet. 2015;24:9&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4262490</ArticleId><ArticleId IdType="pubmed">25122661</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochemistry. 2009;111:1051&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Militello G, et al. A novel long non-coding RNA Myolinc regulates myogenesis through TDP-43 and Filip1. J. Mol. Cell Biol. 2018;10:102&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7191624</ArticleId><ArticleId IdType="pubmed">29618024</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong YH, et al. Tdp-43 cryptic exons are highly variable between cell types. Mol. Neurodegener. 2017;12:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289002</ArticleId><ArticleId IdType="pubmed">28153034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohagheghi F, et al. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor. Hum. Mol. Genet. 2016;25:534&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731020</ArticleId><ArticleId IdType="pubmed">26614389</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga A, et al. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One. 2012;7:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3416794</ArticleId><ArticleId IdType="pubmed">22900096</ArticleId></ArticleIdList></Reference><Reference><Citation>Askanas V, Engel WK, Nogalska A. Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochim. Biophys. Acta. 2015;1852:633&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">25241263</ArticleId></ArticleIdList></Reference><Reference><Citation>Askanas V, Engel WK, Nogalska A. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis. J. Neuropathol. Exp. Neurol. 2012;71:680&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">22805774</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. 2013;110:736&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia M, et al. A highly conserved program of neuronal microexons Is misregulated in autistic brains. Cell. 2014;159:1511&#x2013;1523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4390143</ArticleId><ArticleId IdType="pubmed">25525873</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo G, Holste D, Kreiman G, Burge CB. Variation in alternative splicing across human tissues. Genome Biol. 2004;102:2850&#x2013;2855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545594</ArticleId><ArticleId IdType="pubmed">15461793</ArticleId></ArticleIdList></Reference><Reference><Citation>Green CJ, Gazzara MR, Barash Y. MAJIQ-SPEL: web-tool to interrogate classical and complex splicing variations from RNA-Seq data. Bioinformatics. 2018;34:300&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263396</ArticleId><ArticleId IdType="pubmed">28968636</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehmood A, et al. Systematic evaluation of differential splicing tools for RNA-seq studies. Brief. Bioinforma. 2020;21:2052&#x2013;2065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7711265</ArticleId><ArticleId IdType="pubmed">31802105</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins eeveals strong association with RNA splicing and translation machinery. J. Proteome Res. 2010;9:1104&#x2013;1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese A, et al. Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy. Eur. J. Neurol. 2018;25:154&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pubmed">29029362</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Roczniak-Ferguson, A. &amp; Ferguson, S. M. Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis. Life Sci. Alliance2, 1&#x2013;12 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6749094</ArticleId><ArticleId IdType="pubmed">31527135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, et al. Mice with endogenous TDP&#x2010;43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018;37:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraemer BC, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 2010;119:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2880609</ArticleId><ArticleId IdType="pubmed">20198480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapial J, et al. An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms. Genome Res. 2017;27:1759&#x2013;1768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630039</ArticleId><ArticleId IdType="pubmed">28855263</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S, et al. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. EMBO J. 2016;35:1504&#x2013;1521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa-Morais NL, et al. The evolutionary landscape of alternative splicing in vertebrate species. Science. 2012;338:1587&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pubmed">23258890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gueroussov S, et al. An alternative splicing event amplifies evolutionary differences between vertebrates. Science. 2015;349:868&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pubmed">26293963</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj B, Blencowe BJ. Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles. Neuron. 2015;87:14&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">26139367</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain. 2007;130:1386&#x2013;1394.</Citation><ArticleIdList><ArticleId IdType="pubmed">17439983</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashi S, et al. Concurrence of TDP-43, tau and &#x3b1;-synuclein pathology in brains of Alzheimer&#x2019;s disease and dementia with Lewy bodies. Brain Res. 2007;1184:284&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">17963732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella R, et al. Quantification of the relative contributions of loss-of-function and gain-of-function mechanisms in TAR DNA-binding protein 43 (TDP-43) proteinopathies. J. Biol. Chem. 2016;291:19437&#x2013;19448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5016682</ArticleId><ArticleId IdType="pubmed">27445339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese A, et al. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy. Neurobiol. Aging. 2014;35:1491&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988933</ArticleId><ArticleId IdType="pubmed">24462217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, et al. CYLD dysregulation in pathogenesis of sporadic inclusion body myositis. Sci. Rep. 2019;9:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6690995</ArticleId><ArticleId IdType="pubmed">31406156</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Romano M, Baralle FE. TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls. Mol. Cell. Neurosci. 2013;56:465&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">23500590</ArticleId></ArticleIdList></Reference><Reference><Citation>Highley JR, et al. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones: Amyotrophic lateral sclerosis, TDP-43 and mRNA splicing. Neuropathol. Appl. Neurobiol. 2014;40:670&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">24750229</ArticleId></ArticleIdList></Reference><Reference><Citation>Barr&#xe8;s R, et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 2012;15:405&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">22405075</ArticleId></ArticleIdList></Reference><Reference><Citation>McGee SL, Hargreaves M. Histone modifications and exercise adaptations. J. Appl. Physiol. 2011;110:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">21030677</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasconi V, Puri PL. Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration. Trends Cell Biol. 2009;19:286&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2807132</ArticleId><ArticleId IdType="pubmed">19394225</ArticleId></ArticleIdList></Reference><Reference><Citation>Morosetti R, et al. Increased aging in primary muscle cultures of sporadic inclusion-body myositis. Neurobiol. Aging. 2010;31:1205&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pubmed">18823681</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokach O, et al. Epigenetic changes as a common trigger of muscle weakness in congenital myopathies. Hum. Mol. Genet. 2015;24:4636&#x2013;4647.</Citation><ArticleIdList><ArticleId IdType="pubmed">26019235</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini M, et al. TDP-43 mutations link amyotrophic lateral sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLoS Genet. 2020;16:1&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755276</ArticleId><ArticleId IdType="pubmed">33301444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood M, et al. TDP-43 dysfunction results in R-loop accumulation and DNA replication defects. J. Cell Sci. 2020;133:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7648616</ArticleId><ArticleId IdType="pubmed">32989039</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rkman A, et al. Human RTEL1 associates with Poldip3 to facilitate responses to replication stress and R-loop resolution. Genes Dev. 2020;34:1065&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397856</ArticleId><ArticleId IdType="pubmed">32561545</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, et al. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 2009;583:394&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">19111550</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso-Moreira M, et al. Developmental gene expression differences between humans and mammalian models. Cell Rep. 2020;33:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610014</ArticleId><ArticleId IdType="pubmed">33113372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Pyl PT, Huber W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods. 2008;5:621&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">18516045</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol. 2010;11:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218662</ArticleId><ArticleId IdType="pubmed">20979621</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolde, R. pheatmap: Pretty Heatmapshttps://cran.r-project.org/web/packages/pheatmap/index.html (2019).</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computinghttps://www.r-project.org/ (2019).</Citation></Reference><Reference><Citation>Shen S, et al. rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-seq data. Proc. Natl Acad. Sci. USA. 2014;111:5593&#x2013;5601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280593</ArticleId><ArticleId IdType="pubmed">25480548</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, A.-L. et al. Common ALS/FTD Risk Variants in UNC13A Exacerbate its Cryptic Splicing and Loss Upon TDP-43 Mislocalization10.1101/2021.04.02.438170 (2021).</Citation></Reference><Reference><Citation>Ashburner M, et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 2000;25:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: An R Package for comparing biological themes among gene clusters. OMICS: A J. Integr. Biol. 2012;16:284&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20:110&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798823</ArticleId><ArticleId IdType="pubmed">19858363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent WJ, Zweig AS, Barber G, Hinrichs AS, Karolchik D. BigWig and BigBed: enabling browsing of large distributed datasets. Bioinformatics. 2010;26:2204&#x2013;2207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922891</ArticleId><ArticleId IdType="pubmed">20639541</ArticleId></ArticleIdList></Reference><Reference><Citation>Griggs RC, et al. Inclusion body myositis and myopathies. Ann. Neurol. 1995;38:705&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">7486861</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>